Medical Director @ Regeneron. Oncology Drug Development. Former Pediatric Sarcoma Specialist @ Sloan Kettering. Proud Michigan Wolverine. Cursed sports fan
New York, NY
Joined June 2009
- Tweets978
- Following1.3K
- Followers493
- Likes4.2K
Michael Kinnaman, MD MS retweeted
Jalen Brunson has 45 points on 15-for-25 shooting, eight assists and 0 turnovers against Miami. He just knocked down three free throws to give New York a 10-point lead with 90 seconds left in regulation. Remarkable game from the Knick captain.
Michael Kinnaman, MD MS retweeted
Astoria Park checking in as well!!
Michael Kinnaman, MD MS retweeted
Monday's Weather Rating: 5/10
Sunny once again, with high temperatures in the mid 40s - which feels almost tropical after this cold pattern we've been in! It's a bit windy again, but we're not complaining too much. The vibes are alright!
When people hear I’m a pediatric oncologist, they often say, 'That must be so tough.' And it is—there’s heartbreak, hard days, and emotional valleys. (1/2)
When 3-year-old Calum was diagnosed with cancer, his mother, Caitlin, well-known by followers of her blog Big Time Adulting, found @MDKinnz, a Conquer Cancer-funded researcher who was there for Calum every step of the way.
Read their full story: brnw.ch/21wPyQ2
Michael Kinnaman, MD MS retweeted
Poignant moment here in Jalen Brunson’s on-court interview w/@alanhahn. Brunson had 40 pts to help lift short-handed NYK to win over Indy on night he made 1st All Star Game. He gets choked up when Hahn asks about MVP chants from MSG/confluence of events:
My Mona Lisa is out in @CR_AACR!
Many thanks to @ciacobu for taking a chance on me and being an incredible mentor along the way!
Also this work couldn’t have been without the foundational support of @RallyFoundation @hopeonwheels @quadwfoundation @ConquerCancerFd - 🙏🙏
From the latest issue—
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent #Osteosarcoma, by @MDKinnz et al.
bit.ly/3Gmw7V9
@MSKCancerCenter
Michael Kinnaman, MD MS retweeted
From the latest issue—
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent #Osteosarcoma, by @MDKinnz et al.
bit.ly/3Gmw7V9
@MSKCancerCenter
Michael Kinnaman, MD MS retweeted
State Sen. Nathan Dahm (R-OK) has penned several bills loosening gun restrictions, including the nation’s first anti-red flag law. He thinks these bills protect the Second Amendment – and that they make us safer. We think it's probably one or the other. Watch it on @AppleTVPlus.
Michael Kinnaman, MD MS retweeted
Look at these @UMichFootball TD plays 😲
▶️ 69-yard pass
▶️ 75-yard pass
▶️ 45-yard pass
▶️ 75-yard run
▶️ 85-yard run
Michael Kinnaman, MD MS retweeted
Thanks to @seppobauer @janeway_MD and congratulations to all presenters (@APConley77 @jalivingston_md @MDKinnz @JessicaDaleyMD1) for a terrific session on #bonesarcoma #ewing #osteosarcoma #chordoma! @ctosociety #CTOSTweeTOS @IRCCS_Rizzoli #foster – at Vancouver, British Columbia
Michael Kinnaman, MD MS retweeted
@MDKinnz presented data on behalf of @MSKCancerCenter group: #longterm outcomes of #ifosfamide #intensive treatment of #Ewing #sarcoma in #children and #youngadults. ⬆️ ifos; ⬇️ dox. #Survival better in younger age group. Reason 🙋♂️❓Tolerable in adults. #CTOS2022 #CTOSTweeTOS
Wow that’s high praise! Thank you Sabine for your kind words - and to @AgentsMIB for this incredible opportunity!
"This was such a great presentation…I have a better understanding of my son’s cancer now...Thank goodness there are brilliant minds like that of Dr. Kinnaman (@MDKinnz ) working on this!!!" -Sabine, OsteoMom
Watch now: youtu.be/bd622SL6swE
Looking forward to talking a little Darwin and osteosarcoma this afternoon!
🔬TODAY "How Osteosarcoma Evolves from Diagnosis to Relapse" - @MDKinnz of @MSKCancerCenter is joining us on OsteoBites to talk about this evolution.
👉You can join us LIVE today, Thursday at 3pm EDT:
us02web.zoom.us/webinar/regi…
✨This episode is sponsored by @osinstitute (OSI)
Had a blast this morning sharing a snapshot of my work studying clonal evolution in osteosarcoma! Work made possible by the support of many generous foundations including @ConquerCancerFd @hopeonwheels @quadwfoundation @RallyFoundation.
Hoping to share the full story soon!#ASCO22
Superstar @EmilySlotkin presenting early results of her investigator initiated study which combined irinotecan with the CHEK-1 inhibitor prexasertib for patients with RMS or DSRCT. 32% ORR of a mostly DSRCT cohort! Proof small IITs for rare cancers feasible - Bravo Dr.Slotkin!
Also beautiful bench to bedside story - translating work done in the Andrew Kung lab @MSKCancerCenter utilizing PDX models for these rare tumors to prioritize this agent for clinical trial. @MSKSarcoma @WTapMD @JGladeBender #ASCO2022 #needmoreprexa